Why Pfizer Is Pulling Back on Research Into Rare Disease, Gene Therapy

Pfizer is planning to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies, the company told employees on Thursday afternoon...

Starwood REIT, Like BREIT, Limits Investor Redemptions From Real Estate Fund

Another big nontraded real estate fund is limiting investor redemptions.        Starwood Real Estate Income Trust, a nontraded real estate investment trust, is curbing redemptions after investor withd...

WestCap, a Private-Equity Firm, Marks Down Celsius as Near-Total Loss

Text size Alex Mashinsky, CEO of Celsius Network. Benjamin Girette/Bloomberg Less than a year ago, private-equity investors and a pension fund touted Celsius Network as a “world-class business.” Now t...

Carvana Sought to Disrupt Auto Sales. It Delivered Undriveable Cars.

Terri Burton wanted to do something special to mark her son’s high school graduation, so she bought him the car of his youthful dreams: a Volkswagen Golf GTI. But the purchase was the start of a night...

Asana CEO Has Bought $1 Billion of Company Stock in Historic Buying Spree

Text size Asana co-founder and CEO Dustin Moskovitz has bought more than $1 billion worth of the company’s stock since last June. Courtesy Asana In what is likely the most aggressive run of insi...

Cathie Wood Is Sticking With ARK’s “Super Growth” Stocks–and Avoiding the FAANGs

Opinions on Cathie Wood run strong. “She knows nothing more than anyone else,” one reader all-capped me in an email this past week. I think value investors have been waiting so long for a momentum-sto...